相关实验视频
Updated: Jun 24, 2025

11:58
Primary Culture of Mouse Dopaminergic Neurons
Published on: September 8, 2014
38.0K
多巴胺的神经毒理学:受害者还是攻击者?
Meghan L Bucher1, Jocelyn Dicent1, Carolina Duarte Hospital1
1Department of Environmental Health Sciences, Mailman School of Public Health at Columbia University, New York, NY 10032, USA.
Neurotoxicology
|June 10, 2024
概括
多巴胺可以通过成为神经毒素来伤害大脑细胞,受遗传学和环境的影响. 了解多巴胺毒性是治疗像帕金森病这样的神经系统疾病的关键.
科学领域:
- 神经科学是一个神经科学.
- 毒理学 毒理学 毒理学
- 生物化学 生物化学
背景情况:
- 多巴胺被确定为神经递质,已被研究其在恒温和神经系统疾病中的作用.
- 动物基因模型揭示了多巴胺失调的后果.
- 多巴胺可以作为内源性神经毒素,通过活性氧物种和代谢物损害细胞.
研究的目的:
- 为了提供关于多巴胺毒性的基础知识.
- 为了覆盖破坏多巴胺平衡的内源和外源因素.
- 解释多巴胺作为内源性神经毒素的作用.
主要方法:
- 关于多巴胺平衡和神经毒性的科学文献的综述.
- 对遗传动物模型的分析.
- 检查影响多巴胺水平的内源和外源因素.
主要成果:
- 多巴胺平衡是由复杂的内源和外源因素调节的.
- 多巴胺本身可以导致细胞功能障碍和神经毒性.
- 帕金森病是由于遗传和环境影响导致多巴胺失调的例子.
结论:
- 多巴胺失调与神经退行性疾病有关.
- 遗传和环境等因素显著影响多巴胺平衡.
- 多巴胺在神经毒性中既可以是受害者,也可以是事者.
相关概念视频
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Parkinson's Disease: Overview
527
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
527
Parkinson's Disease: Treatment
257
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
257
Neurochemical Transmission: Sites of Drug Action
2.2K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.2K
Disorders of the Nervous Tissue
1.1K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.1K
Excitatory and Inhibitory Effects of Neurotransmitters
9.9K
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
9.9K

